[HTML][HTML] Chronic kidney disease-induced muscle atrophy: molecular mechanisms and promising therapies
K Wang, Q Liu, M Tang, G Qi, C Qiu, Y Huang… - Biochemical …, 2023 - Elsevier
Chronic kidney disease (CKD) is a high-risk chronic catabolic disease due to its high
morbidity and mortality. CKD is accompanied by many complications, leading to a poor …
morbidity and mortality. CKD is accompanied by many complications, leading to a poor …
Hypoxia‐inducible factor stabilisers for the anaemia of chronic kidney disease
P Natale, SC Palmer, A Jaure… - Cochrane Database …, 2022 - cochranelibrary.com
Background Anaemia occurs in chronic kidney disease (CKD) and is more prevalent with
lower levels of kidney function. Anaemia in CKD is associated with death related to …
lower levels of kidney function. Anaemia in CKD is associated with death related to …
[HTML][HTML] The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney …
The ASCEND-NHQ trial evaluated the effects of daprodustat on hemoglobin and the Medical
Outcomes Study 36-item Short Form Survey (SF-36) Vitality score (fatigue) in a multicenter …
Outcomes Study 36-item Short Form Survey (SF-36) Vitality score (fatigue) in a multicenter …
Comparison of outcomes on hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) in anaemia associated with chronic kidney disease: network meta …
A Sackeyfio, RD Lopes, CP Kovesdy… - Clinical Kidney …, 2024 - academic.oup.com
Background Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) are oral
alternatives to current standard-of-care treatments for anaemia in chronic kidney disease …
alternatives to current standard-of-care treatments for anaemia in chronic kidney disease …
Anaemia and quality of life in chronic kidney disease: a consensus document from the European Anaemia of CKD Alliance
I Dasgupta, CI Bagnis, M Floris, H Furuland… - Clinical kidney …, 2024 - academic.oup.com
Anaemia is common in chronic kidney disease (CKD) and has a significant impact on quality
of life (QoL), work productivity and outcomes. Current management includes oral or …
of life (QoL), work productivity and outcomes. Current management includes oral or …
Drug-related problems and associated factors among patients with kidney dysfunction at a tertiary hospital in southwestern Uganda: a prospective observational study
J Kyomya, F Atwiine, EA Shegena, R Muhindo… - BMC nephrology, 2023 - Springer
Background Kidney dysfunction is a common, progressive condition that is increasingly
becoming a global public health issue. Because the kidneys are the major route for drug …
becoming a global public health issue. Because the kidneys are the major route for drug …
Association of dietary iron intake with diabetic kidney disease among individuals with diabetes
Y Wu, M Xiao, J Chen, Y Tao, A Chen, H Lin, Y Xu, L Li… - Endocrine, 2024 - Springer
Purpose The current study investigated the correlation between dietary iron intake and
diabetic kidney disease among diabetic adults. Methods This cross-sectional study enrolled …
diabetic kidney disease among diabetic adults. Methods This cross-sectional study enrolled …
Efficacy, Safety and Pharmacoeconomic Analysis of Intravenous Ferric Carboxymaltose in Anemic Hemodialysis Patients Unresponsive to Ferric Gluconate Treatment …
A Rosati, P Conti, P Berto, S Molinaro, F Baldini… - Journal of Clinical …, 2022 - mdpi.com
Patients undergoing hemodialysis with iron deficiency anemia (IDA) receiving treatment with
erythropoiesis-stimulating agents (ESAs) who were intolerant or non-responsive to …
erythropoiesis-stimulating agents (ESAs) who were intolerant or non-responsive to …
Chronic Kidney Disease Interplay with Comorbidities and Carbohydrate Metabolism: A Review
Chronic kidney disease (CKD) poses a global health challenge, engendering various
physiological and metabolic shifts that significantly impact health and escalate the …
physiological and metabolic shifts that significantly impact health and escalate the …
Predictors of quality of life in patients within the first year of commencing haemodialysis based on baseline data from the PIVOTAL trial and associations with the study …
S Bhandari, P Parfrey, C White, SD Anker… - Journal of …, 2023 - Springer
Background Impaired quality of life is common in patients with end-stage kidney disease.
We report the baseline quality of life measures in participants from the PIVOTAL randomized …
We report the baseline quality of life measures in participants from the PIVOTAL randomized …